scholarly article | Q13442814 |
P356 | DOI | 10.1093/JAC/30.SUPPL_A.59 |
P698 | PubMed publication ID | 1399952 |
P2093 | author name string | R. J. Davidson | |
D. J. Hoban | |||
B. Weshnoweski | |||
C. G. Zhanel | |||
L. Palatnick | |||
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 7 | |
P304 | page(s) | 59-65 | |
P577 | publication date | 1992-07-01 | |
P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
P1476 | title | In-vitro activity of streptogramin RP 59500 against staphylococci, including bactericidal kinetic studies | |
P478 | volume | 30 Suppl A |
Q40495770 | Anti-infective treatment in intensive care: the role of glycopeptides |
Q41047747 | Antibacterial activity of quinupristin/dalfopristin. Rationale for clinical use. |
Q54072367 | Antimicrobial activity of quinupristin/dalfopristin, a new injectable streptogramin with a wide Gram-positive spectrum. |
Q33980853 | Bactericidal activity of quinupristin-dalfopristin against Staphylococcus aureus: clindamycin susceptibility as a surrogate indicator |
Q35368590 | Current perspectives on glycopeptide resistance. |
Q35637066 | Daptomycin |
Q54130015 | Evaluation of in vitro activity of quinupristin/dalfopristin and comparator antimicrobial agents against worldwide clinical trial and other laboratory isolates. |
Q54179290 | In vitro activity of RP 59500 (quinupristin/dalfopristin) against antibiotic-resistant strains of Streptococcus pneumoniae and Enterococci |
Q71694355 | Quinupristin-dalfopristin |
Q41142608 | Quinupristin/dalfopristin (RP 59500): a new streptogramin antibiotic |
Q28143533 | Quinupristin/dalfopristin: a review of its use in the management of serious gram-positive infections |
Q35218009 | Role of quinupristin/dalfopristin in the treatment of Gram-positive nosocomial infections in haematological or oncological patients |
Q41047740 | Streptogramins. A unique class of antibiotics. |
Q77695934 | Susceptibility of coagulase-negative staphylococci to teicoplanin |
Q40391918 | Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy |
Search more.